ANDA 83741, held by Ivax Sub Teva Pharms. Chlordiazepoxide Hydrochloride.
As of Nov 16, 2026, ANDA 83741 (Chlordiazepoxide Hydrochloride), held by Ivax Sub Teva Pharms, was first approved by FDA on Mar 7, 1975, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 7, 1975 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlordiazepoxide Hydrochloride5MG ยท capsule;oral | Chlordiazepoxide Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters